Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Warner Bros
WBD
|
+$130M |
| 2 |
Tesla
TSLA
|
+$76.4M |
| 3 |
Roblox
RBLX
|
+$50.1M |
| 4 |
VICI Properties
VICI
|
+$43.2M |
| 5 |
Danaher
DHR
|
+$41.2M |
Top Sells
| 1 |
AT&T
T
|
+$209M |
| 2 |
CERN
Cerner Corp
CERN
|
+$119M |
| 3 |
Baidu
BIDU
|
+$91.9M |
| 4 |
Canadian National Railway
CNI
|
+$53.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$37.5M |
Sector Composition
| 1 | Technology | 26.45% |
| 2 | Healthcare | 15.87% |
| 3 | Consumer Discretionary | 11.68% |
| 4 | Communication Services | 8.96% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Mission Produce
AVO
$900M
| $1.42M | ﹤0.01% |
99,800
+66,400
| +199% | +$946K |
|
|
FBMS
2152
DELISTED
The First Bancshares, Inc.
FBMS
| $1.42M | ﹤0.01% |
49,730
| – | – |
|
2153
BridgeBio Pharma
BBIO
$9.79B
| $1.42M | ﹤0.01% |
156,500
+17,300
| +12% | +$157K |
|
2154
PureCycle Technologies
PCT
$2.4B
| $1.42M | ﹤0.01% |
191,500
+14,100
| +8% | +$105K |
|
|
SAFE
2155
DELISTED
Safehold Inc.
SAFE
| $1.42M | ﹤0.01% |
40,100
| – | – |
|
|
SRNE
2156
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.42M | ﹤0.01% |
704,000
+15,900
| +2% | +$32K |
|
2157
Aclaris Therapeutics
ACRS
$211M
| $1.41M | ﹤0.01% |
101,000
-7,500
| -7% | -$105K |
|
2158
OrthoPediatrics
KIDS
$493M
| $1.41M | ﹤0.01% |
32,600
| – | – |
|
2159
Outset Medical
OM
$243M
| $1.41M | ﹤0.01% |
6,307
| – | – |
|
2160
Clear Secure
YOU
$3.58B
| $1.41M | ﹤0.01% |
70,300
| – | – |
|
2161
Franklin Covey
FC
$240M
| $1.4M | ﹤0.01% |
+30,400
| New | +$1.4M |
|
2162
Trustco Bank Corp NY
TRST
$746M
| $1.4M | ﹤0.01% |
45,520
| – | – |
|
2163
Carriage Services
CSV
$670M
| $1.4M | ﹤0.01% |
35,371
-2,300
| -6% | -$91.2K |
|
2164
Central Pacific Financial
CPF
$826M
| $1.4M | ﹤0.01% |
65,200
-1,000
| -2% | -$21.5K |
|
2165
Gorman-Rupp
GRC
$1.13B
| $1.4M | ﹤0.01% |
49,447
| – | – |
|
|
FBRT
2166
Franklin BSP Realty Trust
FBRT
$935M
| $1.4M | ﹤0.01% |
103,533
+15,200
| +17% | +$205K |
|
|
RFP
2167
DELISTED
Resolute Forest Products Inc.
RFP
| $1.4M | ﹤0.01% |
+109,400
| New | +$1.4M |
|
2168
Argan
AGX
$3.18B
| $1.39M | ﹤0.01% |
37,300
| – | – |
|
2169
HCI Group
HCI
$2.34B
| $1.39M | ﹤0.01% |
20,500
+1,100
| +6% | +$74.5K |
|
2170
A-Mark Precious Metals
AMRK
$664M
| $1.39M | ﹤0.01% |
43,000
+2,800
| +7% | +$90.3K |
|
|
DX
2171
Dynex Capital
DX
$1.63B
| $1.38M | ﹤0.01% |
86,633
| – | – |
|
|
STKL
2172
SunOpta
STKL
$740M
| $1.38M | ﹤0.01% |
178,725
| – | – |
|
2173
Northfield Bancorp
NFBK
$492M
| $1.38M | ﹤0.01% |
105,600
| – | – |
|
|
CSII
2174
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.38M | ﹤0.01% |
95,800
| – | – |
|
2175
National Research Corp
NRC
$369M
| $1.37M | ﹤0.01% |
35,900
+2,800
| +8% | +$107K |
|